We are live on ! Find out more
AH

Aviva Holdings Portfolio holdings

AUM $20.5M
1-Year Est. Return 117.01%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
+117.01%
3 Year Est. Return
-36.54%
5 Year Est. Return
-22.08%
10 Year Est. Return
–
AUM
$171M
AUM Growth
-$21.6M
Cap. Flow
-$6.88M
Cap. Flow %
-4.03%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
2
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
MGNX icon
MacroGenics
MGNX
+$12.5M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$3.96M

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$23.4M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDCO
1
DELISTED
Medicines Co
MDCO
$84.1M 49.24%
3,075,302
-758,697
-20% -$23.4M
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$57.2M 33.52%
3,135,966
+255,264
+9% +$3.96M
MGNX icon
3
MacroGenics
MGNX
$263M
$15M 8.76%
787,260
+671,346
+579% +$12.5M
ESPR
4
DELISTED
Esperion Therapeutics
ESPR
$14.5M 8.49%
289,100
– –

Similar funds

MFAM
M Financial Asset Management Portland, Oregon $20.6M AUM 4.99% 1-Year Est. Return
SL
Stevard LLC Chicago, Illinois $26.8M AUM 42.43% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
SFG
Susquehanna Financial Group Bala Cynwyd, Pennsylvania $10.9M AUM
CGI
Calixto Global Investors Coral Gables, Florida $30.7M AUM 111.27% 1-Year Est. Return
VFA
Virtus Fund Advisers Hartford, Connecticut $32.1M AUM 39.5% 1-Year Est. Return
AMG
Ace Management Global Sao Paulo, Brazil $7.88M AUM 47.04% 1-Year Est. Return

Aviva Holdings's Q4 2017 Portfolio in Review

As of Q4 2017, Aviva Holdings held 4 positions worth $171M, down 11% from $192M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Aviva Holdings withdrew a net $6.88M in Q4 2017, reducing 1 holding. Its largest reduction was Medicines Co, cutting an estimated $23.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Aviva Holdings added an estimated $12.5M to MacroGenics.

  • Aviva Holdings added most to MacroGenics in Q4 2017, an estimated $12.5M increase.
  • Aviva Holdings's biggest Q4 2017 reduction was Medicines Co, cutting an estimated $23.4M.
  • Aviva Holdings's ten largest holdings make up 100% of its $171M portfolio in Q4 2017.
  • Aviva Holdings opened 0 new positions and closed 0 in Q4 2017.
  • Aviva Holdings's portfolio value fell 11% quarter-over-quarter to $171M.

Based on Aviva Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.